Sort
50,496 grants matching “lung cancer”
Human CYP2A and respiratory tract xenobiotic toxicity
$402,884Xinxin Ding · University Of Arizona · R01 · FY2017 · CA
The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy
$402,874Qing Yang · University Of Texas Med Br Galveston · R01 · FY2025 · CA
The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy
$402,874Qing Yang · University Of Texas Med Br Galveston · R01 · FY2024 · CA
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss
$402,857Tal Teitz · Creighton University · R01 · FY2021 · DC
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss
$402,857Tal Teitz · Creighton University · R01 · FY2023 · DC
CORALE-SeroNet Project 2
$402,829Noah M Merin · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Tubulin microtentacles in detached mammary epithelial cells
$402,817Stuart S Martin · University Of Maryland Baltimore · R01 · FY2024 · CA
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$402,791Michael Lim · Stanford University · R01 · FY2022 · NS
Lung Navigation System for Localizing and Resecting Nodules
$402,750Jayender Jagadeesan · Brigham And Women'S Hospital · R01 · FY2019 · EB
Lung Navigation System for Localizing and Resecting Nodules
$402,750Jayender Jagadeesan · Brigham And Women'S Hospital · R01 · FY2020 · EB
Neurohormonal Blockade and Outcomes in Diastolic Heart Failure
$402,689Ali Ahmed · University Of Alabama At Birmingham · R01 · FY2010 · HL
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy
$402,645Roman Perez-Soler · Albert Einstein College Of Medicine · R01 · FY2012 · CA
Gene Analysis Shared Resource
$402,631Eric D Wieben · Mayo Clinic Rochester · P30 · FY2014 · CA
Studies on the effects of a novel intermittent therapy on intratumoral clonal architecture and resistance
$402,618Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Novel therapies for cigarette smoke induced lung injury
$402,612Patricia Janet Sime · University Of Rochester · R01 · FY2014 · HL
Single Cell Profiling and In Vivo Cellular Interrogation of Alveolar Stem Cells
$402,607Tushar Jasubhai Desai · Stanford University · R56 · FY2015 · HL
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
$402,605Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity
$402,600Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Interrogation of MLL2 as a tumor suppressor gene in lung cancer
$402,600David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance
$402,600Cyrus M Ghajar · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$402,600Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Interrogation of MLL2 as a tumor suppressor gene in lung cancer
$402,600David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Interrogation of MLL2 as a tumor suppressor gene in lung cancer
$402,600David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$402,600Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Role of tumor cell cluster-induced signaling in breast cancer metastasis
$402,600Kevin Jon Cheung · Fred Hutchinson Cancer Research Center · R37 · FY2020 · CA